Cite
DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A
MLA
Rangel L, Silva, et al. “DMH-CBD, a Cannabidiol Analog with Reduced Cytotoxicity, Inhibits TNF Production by Targeting NF-KB Activity Dependent on A.” Toxicology and Applied Pharmacology, vol. 368, Aug. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........aaf5b043299ef5252d4b8d652b32c273&authtype=sso&custid=ns315887.
APA
Rangel L, S., Gabriela T, S., Carlos W, W., Nerry T, C., Alexandre G M, M., Marcelo, F., Lucas M M, M., Norberto P, L., José A, C., Francisco S, G., José C F, A.-F., Fernando Q, C., & Thiago M, C. (2018). DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A. Toxicology and Applied Pharmacology, 368.
Chicago
Rangel L, Silva, Silveira Gabriela T, Wanderlei Carlos W, Cecilio Nerry T, Maganin Alexandre G M, Franchin Marcelo, Marques Lucas M M, et al. 2018. “DMH-CBD, a Cannabidiol Analog with Reduced Cytotoxicity, Inhibits TNF Production by Targeting NF-KB Activity Dependent on A.” Toxicology and Applied Pharmacology 368 (August). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........aaf5b043299ef5252d4b8d652b32c273&authtype=sso&custid=ns315887.